ANGPT1 and carcinoma: Inhibition of the angiopoietin/Tie2 pathway, using the peptibodies mL4-3 and L1-7(N) to neutralize the binding of Ang1 and Ang2 to Tie2, rendered human carcinoma cell lines of the breast, prostate, and ovary significantly more sensitive to T cell-mediated attack.